Your browser doesn't support javascript.
loading
[Prognostic factors for surgical cure in acromegaly]
Revue Maghrebine d'Endocrinologie-Diabete et de Reproduction [La]. 2007; 12 (3): 125-129
in Fr | IMEMR | ID: emr-85005
Responsible library: EMRO
Surgery is the treatment of choice in acromegaly. To determine the prognostic factors for surgical cure in growth hormone secreting pituitary adenomas, we studied 35 patients who underwent surgery between 1986 and 2005. We compared the clinical, biological and tumoral characteristics of the cured group [n=19] and those of the non cured group [n=16]. A young age and in invasive adenoma were factors for a poor surgical prognosis. Other factors for bad surgical prognosis are reported in the literature such as a preoperative GH level higher than 50 ng/ml, a monohormonal finding at immunohistochemistry and no GH suppression after surgery
Subject(s)
Search on Google
Index: IMEMR Main subject: Prognosis / Growth Hormone / Retrospective Studies / Growth Hormone-Secreting Pituitary Adenoma Type of study: Observational_studies / Prognostic_studies Limits: Female / Humans / Male Language: Fr Journal: Rev. Maghreb. Endocrinol.-Diabete Reprod. Year: 2007
Search on Google
Index: IMEMR Main subject: Prognosis / Growth Hormone / Retrospective Studies / Growth Hormone-Secreting Pituitary Adenoma Type of study: Observational_studies / Prognostic_studies Limits: Female / Humans / Male Language: Fr Journal: Rev. Maghreb. Endocrinol.-Diabete Reprod. Year: 2007